Charles Naveenan Antonypillai
Charles Naveenan Antonypillai has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Dhulashiha Jegavanthan
General Hospital (Teaching), Kandy
4 shared publications - G. M. Gajaweera
National Hospital Kandy
4 shared publications - Kushalee Poornima Jayawickreme
University of Colombo, Sri Lanka
4 shared publications - C. G. K. Amiyangoda
Department of Pharmacology, Faculty of Medicine, University of Peradeniya, Sri Lanka
2 shared publications - K. A. N. Ravindu2 shared publications
- Noel Pratheepan Somasundaram
Diabetes and Endocrine Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka
2 shared publications
Latest Publications
- Open Access
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 59-63
A Case of Primary Adrenal Lymphoma: How Do We Detect Early Progression to Adrenal Insufficiency?
Introduction: Diffused large B cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin’s lymphoma. Non-Hodgkins lymphoma arising in endocrine organs account for 3% of extra-nodal malignant lymphoma, and Primary adrenal lymphoma account for only 0.2% of them. Primary adrenal lymphoma involves the bilateral adrenals in 70% cases, and can cause adrenal insufficiency even if the lesion is unilateral.Case Description: We present a 60-year-old female, who presented with constitutional symptoms and dyspnoea. On examination she was underweight, had marginally low blood pressure, and was desaturated. She had hyponatremia and high lactate dehydrogenase levels. 2D echocardiogram showed two echogenicmasses: one in the anterior pericardial space, and another in the right atrium obstructing the tricuspid origin. Ultrasound scan showed a left suprarenal mass, and bilateral pleural effusions. CECT showed the same enhancing mass involving tricuspid valve, which was extending into the right atrium, and right ventricle causing luminal narrowing and an enhancing solid lesion in the left adrenal gland (HU 30.8). 9am cortisol was 422 nmol/L, with high serum ACTH. She developed hypotension which responded to IV hydrocortisone. Adrenal biopsy revealed high grade DLBCL with Ki 67 index of 80%. She suddenly succumbed before definitive treatment.Conclusion: Adrenal insufficiency in the setting of a unilateral non secretory adrenal lesion should rise the suspicion of Primary adrenal lymphoma rather than adrenal metastasis. Similarly, when biopsy of an adrenal lesion reveals Primary adrenal lymphoma rather than metastasis, there should be a higher index of suspicion to detect the presence of or progression to early adrenal insufficiency, even if the lesion is unilateral.
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 59-63
Open AccessA Case of Primary Adrenal Lymphoma: How Do We Detect Early Progression to Adrenal Insufficiency?
Introduction: Diffused large B cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin’s lymphoma. Non-Hodgkins lymphoma arising in endocrine organs account for 3% of extra-nodal malignant lymphoma, and Primary adrenal lymphoma account for only 0.2% of them. Primary adrenal lymphoma involves the bilateral adrenals in 70% cases, and can cause adrenal insufficiency even if the lesion is unilateral.Case Description: We present a 60-year-old female, who presented with constitutional symptoms and dyspnoea. On examination she was underweight, had marginally low blood pressure, and was desaturated. She had hyponatremia and high lactate dehydrogenase levels. 2D echocardiogram showed two echogenicmasses: one in the anterior pericardial space, and another in the right atrium obstructing the tricuspid origin. Ultrasound scan showed a left suprarenal mass, and bilateral pleural effusions. CECT showed the same enhancing mass involving tricuspid valve, which was extending into the right atrium, and right ventricle causing luminal narrowing and an enhancing solid lesion in the left adrenal gland (HU 30.8). 9am cortisol was 422 nmol/L, with high serum ACTH. She developed hypotension which responded to IV hydrocortisone. Adrenal biopsy revealed high grade DLBCL with Ki 67 index of 80%. She suddenly succumbed before definitive treatment.Conclusion: Adrenal insufficiency in the setting of a unilateral non secretory adrenal lesion should rise the suspicion of Primary adrenal lymphoma rather than adrenal metastasis. Similarly, when biopsy of an adrenal lesion reveals Primary adrenal lymphoma rather than metastasis, there should be a higher index of suspicion to detect the presence of or progression to early adrenal insufficiency, even if the lesion is unilateral.
- Open Access
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 5-11
Etomidate in the Treatment of Severe Cushing Syndrome: The Sri Lankan Experience
Background: Severe Cushing syndrome is a medical emergency requiring immediate supportive and hypocortisolaemic therapy. Urgent treatment of hypercortisolaemia within 24 – 72 hours is recommended to prevent life-threatening complications. Etomidate is the only intravenous option and has the most rapid onset of action out of the drugs used in treating Cushing syndrome.Methods: We present a descriptive retrospective study of 9 patients with severe Cushing syndrome treated with Etomidate infusion at six different hospitals with Endocrine Units in Sri Lanka.Results: On analysis Etomidate used as first-line showed a drop of cortisol of 71%, a mean rate of reduction of cortisol of 104.3 nmol/l/hour, and a duration for cortisol to reach the desired level of 15 hours Low dose Etomidate infusion did not cause adrenal insufficiency irrespective of giving a bolus prior to infusion, but caused adrenal insufficiency only when the Etomidate infusion was commenced at a higher rate.Conclusion: We conclude that Etomidate is potentially a suitable first line treatment in severe Cushing syndrome, especially in a resource poor setting where other therapeutic agents are not accessible
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 5-11
Open AccessEtomidate in the Treatment of Severe Cushing Syndrome: The Sri Lankan Experience
Background: Severe Cushing syndrome is a medical emergency requiring immediate supportive and hypocortisolaemic therapy. Urgent treatment of hypercortisolaemia within 24 – 72 hours is recommended to prevent life-threatening complications. Etomidate is the only intravenous option and has the most rapid onset of action out of the drugs used in treating Cushing syndrome.Methods: We present a descriptive retrospective study of 9 patients with severe Cushing syndrome treated with Etomidate infusion at six different hospitals with Endocrine Units in Sri Lanka.Results: On analysis Etomidate used as first-line showed a drop of cortisol of 71%, a mean rate of reduction of cortisol of 104.3 nmol/l/hour, and a duration for cortisol to reach the desired level of 15 hours Low dose Etomidate infusion did not cause adrenal insufficiency irrespective of giving a bolus prior to infusion, but caused adrenal insufficiency only when the Etomidate infusion was commenced at a higher rate.Conclusion: We conclude that Etomidate is potentially a suitable first line treatment in severe Cushing syndrome, especially in a resource poor setting where other therapeutic agents are not accessible
- Open Access
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 26-33
A Cross-Sectional Study on Clinical Outcome of the Current Management Practice with Carb-Counting & Insulin Titration, & Health-Related Quality of Life (HRQoL) on a Selected Group of Young Adults with Type 1 Diabetes Attending to Diabetes & Endocrinology Unit at National Hospital Kandy, Sri Lanka
Background: Clinical outcome and health related quality of life (HRQoL) assessment among young adults living with type 1 diabetes mellitus (T1DM) following structured education on self-management of diabetes in Sri Lankan settings is unknown.Aims: To assess the clinical outcomes of current management practice with carbohydrate counting and self-management of insulin according to eating patterns and to assess the health-related quality of life (HRQoL) among young adults living with T1DM aged between 18-25.Methods: Thirty young adults aged between 18-25 years with the diagnosis of T1DM, classified according to American Diabetes Association guideline based on the clinical and/or biochemical parameters were recruited in this descriptive cross-sectional study. Basic demographic data, baseline and follow up assessments on HBA1C were recorded. HRQoL assessment was carried out via a self-administered questionnaire (ViDa1) and the results were compared for internal consistency and with the clinical outcomes.Results: Among the 12 male and 18 female patients, an improvement in HBA1C by the mean of 1.2% was noted over a mean period of 11.38 months of carbohydrate counting and 9.52 months of the self-management of insulin, though no statistical significance observed (P=0.698, 95%CI -0.38-2.8). The internal consistency of Vida 1 questionnaire for our population was validated through Cronbach’s alpha > 0.7 in all four subclasses. There was a positive correlation between self-care and wellbeing (P<0.05) as well as wellbeing and concern about illness (P<0.05). The means for self-care and concern about illness were higher at 3.77 and 3.80 respectively. Feeling of wellbeing was associated with higher educational level (P<0.05).Conclusion: Carbohydrate counting and self-management of insulin showed beneficial effects on improving the HbA1C, though there were no statistical significance. Higher educational level had statistically significant association with feeling of wellbeing in patient with T1DM, which could be explained by improvement in self-confidence with better understanding of training. By extending this study in multicentric level with larger sample size might improve the statistical significance in clinical outcome and further follow up study is required to assess the difference in HRQoL with time.
- 12 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (2) , 26-33
Open AccessA Cross-Sectional Study on Clinical Outcome of the Current Management Practice with Carb-Counting & Insulin Titration, & Health-Related Quality of Life (HRQoL) on a Selected Group of Young Adults with Type 1 Diabetes Attending to Diabetes & Endocrinology Unit at National Hospital Kandy, Sri Lanka
Background: Clinical outcome and health related quality of life (HRQoL) assessment among young adults living with type 1 diabetes mellitus (T1DM) following structured education on self-management of diabetes in Sri Lankan settings is unknown.Aims: To assess the clinical outcomes of current management practice with carbohydrate counting and self-management of insulin according to eating patterns and to assess the health-related quality of life (HRQoL) among young adults living with T1DM aged between 18-25.Methods: Thirty young adults aged between 18-25 years with the diagnosis of T1DM, classified according to American Diabetes Association guideline based on the clinical and/or biochemical parameters were recruited in this descriptive cross-sectional study. Basic demographic data, baseline and follow up assessments on HBA1C were recorded. HRQoL assessment was carried out via a self-administered questionnaire (ViDa1) and the results were compared for internal consistency and with the clinical outcomes.Results: Among the 12 male and 18 female patients, an improvement in HBA1C by the mean of 1.2% was noted over a mean period of 11.38 months of carbohydrate counting and 9.52 months of the self-management of insulin, though no statistical significance observed (P=0.698, 95%CI -0.38-2.8). The internal consistency of Vida 1 questionnaire for our population was validated through Cronbach’s alpha > 0.7 in all four subclasses. There was a positive correlation between self-care and wellbeing (P<0.05) as well as wellbeing and concern about illness (P<0.05). The means for self-care and concern about illness were higher at 3.77 and 3.80 respectively. Feeling of wellbeing was associated with higher educational level (P<0.05).Conclusion: Carbohydrate counting and self-management of insulin showed beneficial effects on improving the HbA1C, though there were no statistical significance. Higher educational level had statistically significant association with feeling of wellbeing in patient with T1DM, which could be explained by improvement in self-confidence with better understanding of training. By extending this study in multicentric level with larger sample size might improve the statistical significance in clinical outcome and further follow up study is required to assess the difference in HRQoL with time.
- Open Access
- 19 August 2024
- Published by Bioscientifica in Endocrine Connections
- Vol. 13  (10)
Rapid supervised levothyroxine absorption test in refractory hypothyroidism: suggestion for assessing absorption using two blood samples in low-resource settings
Refractory hypothyroidism is associated with high morbidity and increased healthcare expenditure. In general, the use of the levothyroxine absorption test looks promising in evaluating refractory hypothyroidism but has shown significant variability in protocols in multiple settings. We intended to assess the usefulness of the levothyroxine absorption test in a low-resource setting and to assess the factors associated with refractory hypothyroidism. A cross-sectional study among age-matched 25 cases of refractory hypothyroidism and 24 treatment-responsive hypothyroid controls was conducted. A supervised levothyroxine absorption test was performed with levothyroxine 1000 μg tablets after a 10-h fast, and serum free tetraiodothyronine (FT4) levels were measured at 0, 1, 2, 3, 4, and 5 h. Descriptive statistics, chi-square test, Student’s t-test, and logistic regression were used in the analysis. Results showed no significant difference in age, body weight, etiology of hypothyroidism, interfering medications, thyroxine storage, and ingestion technique in cases and controls. Cases had a longer duration of hypothyroidism and males had a higher peak FT4 concentration. During pooled analysis, serum FT4 peaked at 3 h with an increment of 149.4% (128.4–170.5%) from baseline and plateaued thereafter. The absolute value of FT4 at 3 h was 41.59 (s.d. 14.14) pmol/L (3.23 ng/dL). We concluded that there was no significant difference in the pattern of levothyroxine absorption in both groups. The most common cause of refractory disease was pseudo-malabsorption. Rapid supervised levothyroxine absorption test with two blood samples for FT4 at baseline and at the peak of absorption (3 h) is simple, convenient, and cost-effective, particularly in low-resource settings.
- 19 August 2024
- Published by Bioscientifica in Endocrine Connections
- Vol. 13  (10)
Open AccessRapid supervised levothyroxine absorption test in refractory hypothyroidism: suggestion for assessing absorption using two blood samples in low-resource settings
Refractory hypothyroidism is associated with high morbidity and increased healthcare expenditure. In general, the use of the levothyroxine absorption test looks promising in evaluating refractory hypothyroidism but has shown significant variability in protocols in multiple settings. We intended to assess the usefulness of the levothyroxine absorption test in a low-resource setting and to assess the factors associated with refractory hypothyroidism. A cross-sectional study among age-matched 25 cases of refractory hypothyroidism and 24 treatment-responsive hypothyroid controls was conducted. A supervised levothyroxine absorption test was performed with levothyroxine 1000 μg tablets after a 10-h fast, and serum free tetraiodothyronine (FT4) levels were measured at 0, 1, 2, 3, 4, and 5 h. Descriptive statistics, chi-square test, Student’s t-test, and logistic regression were used in the analysis. Results showed no significant difference in age, body weight, etiology of hypothyroidism, interfering medications, thyroxine storage, and ingestion technique in cases and controls. Cases had a longer duration of hypothyroidism and males had a higher peak FT4 concentration. During pooled analysis, serum FT4 peaked at 3 h with an increment of 149.4% (128.4–170.5%) from baseline and plateaued thereafter. The absolute value of FT4 at 3 h was 41.59 (s.d. 14.14) pmol/L (3.23 ng/dL). We concluded that there was no significant difference in the pattern of levothyroxine absorption in both groups. The most common cause of refractory disease was pseudo-malabsorption. Rapid supervised levothyroxine absorption test with two blood samples for FT4 at baseline and at the peak of absorption (3 h) is simple, convenient, and cost-effective, particularly in low-resource settings.
- Open Access
- 13 August 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 33  (2) , 15-24
Does Thyroidectomy Offer Quality of Life Advantage for Autoimmune Thyroiditis Patients?
Introduction: Significant reduction of subjective health status is frequently reported by many patients with Hashimoto thyroiditis despite adequate thyroxine replacement therapy. Studies have shown that thyroidectomy improves quality of life (QoL) in patients with HT and persistence symptoms, however there are conflicting evidence and we do not have our own data. QoL is an important aspect in management of chronic diseases like hypothyroidism which is less well touched in our population. Our findings highlight the potential of thyroidectomy in enhancing QoL for HT patients, contributing to the ongoing research on optimal management strategies for this condition. Objectives: To assess the QoL in patients with Hashimoto's thyroiditis (HT) who are biochemically euthyroid on thyroxine replacement therapy and to compare the QoL between patients managed medically and those who have undergone thyroidectomy with histologically confirmed HT. Methodology: We conducted a case-control study to compare the QoL using the SF-36 questionnaire among two groups of euthyroid Hashimoto’s thyroiditis patients: those receiving medical management and those who are post-thyroidectomy, as well as a healthy matched control group. Confounders that could affect QoL were rigorously excluded, and parametric tests were utilized for data analysis. Results: A significantly lower overall QoL was noted in the medically managed group (n=23) compared to the thyroidectomy group (n=24), with mean scores of 63.72 versus 84.25, respectively (P-value < 0.0001). This trend was consistent across all domains of the SF-36 QoL questionnaire. The QoL scores of patients who underwent surgery were similar to those of the healthy control group. Additionally, no significant correlation was found between thyroperoxidase (TPO) antibody titers and QoL in the regression analysis. Conclusion: Overall, patients with Hashimoto's thyroiditis on medical management exhibit significantly poorer QoL, despite adequate thyroxine replacement. This may be attributable to a complex interplay of immunological factors associated with an intact thyroid gland. Thyroidectomy could serve as a viable treatment alternative for these individuals. It is essential to develop algorithms to identify patients who would benefit most from thyroidectomy, ensuring they are thoroughly informed about the risks and benefits. Ongoing studies and the establishment of therapeutic guidelines are crucial for improving the management of patients with Hashimoto's thyroiditis.
- 13 August 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 33  (2) , 15-24
Open AccessDoes Thyroidectomy Offer Quality of Life Advantage for Autoimmune Thyroiditis Patients?
Introduction: Significant reduction of subjective health status is frequently reported by many patients with Hashimoto thyroiditis despite adequate thyroxine replacement therapy. Studies have shown that thyroidectomy improves quality of life (QoL) in patients with HT and persistence symptoms, however there are conflicting evidence and we do not have our own data. QoL is an important aspect in management of chronic diseases like hypothyroidism which is less well touched in our population. Our findings highlight the potential of thyroidectomy in enhancing QoL for HT patients, contributing to the ongoing research on optimal management strategies for this condition. Objectives: To assess the QoL in patients with Hashimoto's thyroiditis (HT) who are biochemically euthyroid on thyroxine replacement therapy and to compare the QoL between patients managed medically and those who have undergone thyroidectomy with histologically confirmed HT. Methodology: We conducted a case-control study to compare the QoL using the SF-36 questionnaire among two groups of euthyroid Hashimoto’s thyroiditis patients: those receiving medical management and those who are post-thyroidectomy, as well as a healthy matched control group. Confounders that could affect QoL were rigorously excluded, and parametric tests were utilized for data analysis. Results: A significantly lower overall QoL was noted in the medically managed group (n=23) compared to the thyroidectomy group (n=24), with mean scores of 63.72 versus 84.25, respectively (P-value < 0.0001). This trend was consistent across all domains of the SF-36 QoL questionnaire. The QoL scores of patients who underwent surgery were similar to those of the healthy control group. Additionally, no significant correlation was found between thyroperoxidase (TPO) antibody titers and QoL in the regression analysis. Conclusion: Overall, patients with Hashimoto's thyroiditis on medical management exhibit significantly poorer QoL, despite adequate thyroxine replacement. This may be attributable to a complex interplay of immunological factors associated with an intact thyroid gland. Thyroidectomy could serve as a viable treatment alternative for these individuals. It is essential to develop algorithms to identify patients who would benefit most from thyroidectomy, ensuring they are thoroughly informed about the risks and benefits. Ongoing studies and the establishment of therapeutic guidelines are crucial for improving the management of patients with Hashimoto's thyroiditis.
- Open Access
- 6 August 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18  (2) , 80-84
Hyponatraemia in stroke patients: A single-centre prospective cohort study.
Cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate anti diuretic hormone secretion (SIADH) are the most common aetiological factors for developing hyponatremia following stroke. The differentiation of these two entities is crucial as the treatment options are completely different. The aim of this study is to determine the incidence of aetiologies of hyponatremia and compare demographic, clinical, imaging and laboratory parameters in each groupTwo hundred and forty-six patients with confirmed strokes were prospectively observed throughout the hospital stay in a tertiary referral center in Sri Lanka to identify the possible predictors of CSWS. Hyponatremia was defined as a serum Na+ level less than 131mmo/l. Serum osmolality, urine osmolality, urinary Na+, serum cortisol and thyroid function tests were performed on all the hyponatremic patients. The CSWS and SIADH were differentiated based on physical examination findings and laboratory parameters.The incidence of hyponatremia in our study population was 19.1% (95% Confidence interval, 14.39-24.58). The majority of patients (24, 51%) were attributed to CSWS. SIADH group comprised of 17 (36.2%) patients and 6 (12.7%) patients had other undetermined causes.The incidence of CSWS is higher than the incidence of SIADH among stroke patients in our setting.
- 6 August 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18  (2) , 80-84
Open AccessHyponatraemia in stroke patients: A single-centre prospective cohort study.
Cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate anti diuretic hormone secretion (SIADH) are the most common aetiological factors for developing hyponatremia following stroke. The differentiation of these two entities is crucial as the treatment options are completely different. The aim of this study is to determine the incidence of aetiologies of hyponatremia and compare demographic, clinical, imaging and laboratory parameters in each groupTwo hundred and forty-six patients with confirmed strokes were prospectively observed throughout the hospital stay in a tertiary referral center in Sri Lanka to identify the possible predictors of CSWS. Hyponatremia was defined as a serum Na+ level less than 131mmo/l. Serum osmolality, urine osmolality, urinary Na+, serum cortisol and thyroid function tests were performed on all the hyponatremic patients. The CSWS and SIADH were differentiated based on physical examination findings and laboratory parameters.The incidence of hyponatremia in our study population was 19.1% (95% Confidence interval, 14.39-24.58). The majority of patients (24, 51%) were attributed to CSWS. SIADH group comprised of 17 (36.2%) patients and 6 (12.7%) patients had other undetermined causes.The incidence of CSWS is higher than the incidence of SIADH among stroke patients in our setting.
- Open Access
- 30 May 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (1) , 45-46
From Fingertips to the Diagnosis: Telltale Sign in Nails in a Thyrotoxic Patient
- 30 May 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 15  (1) , 45-46
Open AccessFrom Fingertips to the Diagnosis: Telltale Sign in Nails in a Thyrotoxic Patient
- Open Access
- 31 December 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 32  (2) , 17-25
Effects of COVID-19 lockdown on metabolic control in patients with type 2 diabetes in Sri Lanka
Introduction: The COVID-19 pandemic has led to an island-wide lockdown in Sri Lanka, leading to restrictions in daily routines. The ensuing lifestyle changes have drastically influenced the prevalence and worsening of chronic diseases like diabetes with poor metabolic control of the disease.Objectives: To evaluate the immediate impact of the lockdown on the metabolic parameters associated with diabetes control in individuals with type-2 diabetes mellitus (T2DM).Methodology: A single center cross-sectional descriptive study was conducted on 157 T2DM patients attending a diabetes clinic in the private sector. Pre- and post-lockdown data on metabolic control of the study population was collected from patient records. Patients’ perceptions of diet/exercise and access to medication/medical care during the lockdown were collected through a telephone interview.Results: Pre- and post-lockdown data of 157 male (Females 88; mean age-58.68±SD 13.44 years) patients belonging to the age group 48-72 were evaluated. Of the patients who had a HbA1c of ≤ 7% pre-lockdown, 80% had shown to maintain their HbA1c. Of the patients with HbA1c > 7% pre-lockdown, 27.9% showed a reduction of their HbA1c below 7%.The majority of the responders had no difference in their diet (69.2%) and exercise (65.4%) during the lockdown. Among those with improved HbA1c (n=101;63% of cohort), 16.9% and 13% had better diet and exercise respectively while none in worsened HbA1c group had improved diet or exercise.Conclusions: Lockdown in Sri Lanka has not been associated with worsening of glycaemic control in the studied cohort of patients with type 2 diabetes. Adherence to the recommended diet and exercise regime during lockdown is associated with better glycaemic control in patients with type 2 diabetes.
- 31 December 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 32  (2) , 17-25
Open AccessEffects of COVID-19 lockdown on metabolic control in patients with type 2 diabetes in Sri Lanka
Introduction: The COVID-19 pandemic has led to an island-wide lockdown in Sri Lanka, leading to restrictions in daily routines. The ensuing lifestyle changes have drastically influenced the prevalence and worsening of chronic diseases like diabetes with poor metabolic control of the disease.Objectives: To evaluate the immediate impact of the lockdown on the metabolic parameters associated with diabetes control in individuals with type-2 diabetes mellitus (T2DM).Methodology: A single center cross-sectional descriptive study was conducted on 157 T2DM patients attending a diabetes clinic in the private sector. Pre- and post-lockdown data on metabolic control of the study population was collected from patient records. Patients’ perceptions of diet/exercise and access to medication/medical care during the lockdown were collected through a telephone interview.Results: Pre- and post-lockdown data of 157 male (Females 88; mean age-58.68±SD 13.44 years) patients belonging to the age group 48-72 were evaluated. Of the patients who had a HbA1c of ≤ 7% pre-lockdown, 80% had shown to maintain their HbA1c. Of the patients with HbA1c > 7% pre-lockdown, 27.9% showed a reduction of their HbA1c below 7%.The majority of the responders had no difference in their diet (69.2%) and exercise (65.4%) during the lockdown. Among those with improved HbA1c (n=101;63% of cohort), 16.9% and 13% had better diet and exercise respectively while none in worsened HbA1c group had improved diet or exercise.Conclusions: Lockdown in Sri Lanka has not been associated with worsening of glycaemic control in the studied cohort of patients with type 2 diabetes. Adherence to the recommended diet and exercise regime during lockdown is associated with better glycaemic control in patients with type 2 diabetes.
- Open Access
- 8 August 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 14  (2) , 51-57
A rare case of bilateral Vanishing Testicle Syndrome
Vanishing testicle syndrome (VTS) is due to regression of already formed testes. This could occur at any stage during or after testicular descent due any insult resulting in testicular atrophy. VTS is estimated to affect 1:1250 males. We present a rare case of a 12-year-old boy presenting with absent secondary sexual characteristics and short stature found to have bilateral vanishing testicle syndrome. His testes were impalpable at neonatal examination. At the age of 1.5 years an ultrasound scan detected the right testis in the inguinal ring, measuring 1.5 x 1 cm with features suggestive of ischaemia with likely acute or subacute torsion. The left testes was seen in the inguinal canal already atrophied by that time. Subsequently, on surgical exploration the right testis was found atrophied in the inguinal canal, and was replaced in the right sub-dartose pouch, but left testis could not be identified. Surprisingly, 4 months later laparoscopic exploration failed to identify either of the testes except for bilateral atrophied gubernaculum, indicating testicular regression. At the age of 7 years, magnetic resonance imaging confirmed the absence of either of the testes, with no remnants. On examination his height was 146.5cm, which was between the 25th and 50th percentile for that age, and below his mid-parental height range. He had no androgenic hair growth, testes were impalpable and had a prepubertal penis accounting to tanner stage of 1. He had hypergonadotrophic hypogonadism. Pubertal induction was done with testosterone injections which resulted in height gain and development of secondary sexual characteristics.Introduction: The entity Vanishing testicle syndrome (VTS) was coined by Abryaratne et al. in 1969, and is also referred to as "Testicular regression syndrome" [1][2]. The two essential diagnostic criteria are; visualizing the blind-ending spermatic vessels within the retro-peritoneum or spermatic vessels and vas deferens exiting a closed internal inguinal ring, and Testis not palpated during examination under anaesthesia[2][3]. A small fibrotic nodule or nubbin with dystrophic calcification and haemosiderin deposition is usually found at the end of the spermatic cord, with or without identifiable testicular or para-testicular structures [2][3]. Cryptorchidism is reported in 1 -4.6% full term and 1.1 -45.3% pre-mature male infants [4]. This prevalence of cryptorchidism decreases to 1 % by the age of 1 year [5]. Testes are non-palpable in 10 -20% cases of cryptorchidism, and of these VTS accounts for 35 - 60% [6] VTS occurs in < 5% cases of cryptorchidism [7]. VTS is estimated to affect 1:1250 males [8]. We present a rare case of bilateral VTS in a 12 year old boy who presented with short stature and absent secondary sexual characteristics with unpalpable testes.
- 8 August 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 14  (2) , 51-57
Open AccessA rare case of bilateral Vanishing Testicle Syndrome
Vanishing testicle syndrome (VTS) is due to regression of already formed testes. This could occur at any stage during or after testicular descent due any insult resulting in testicular atrophy. VTS is estimated to affect 1:1250 males. We present a rare case of a 12-year-old boy presenting with absent secondary sexual characteristics and short stature found to have bilateral vanishing testicle syndrome. His testes were impalpable at neonatal examination. At the age of 1.5 years an ultrasound scan detected the right testis in the inguinal ring, measuring 1.5 x 1 cm with features suggestive of ischaemia with likely acute or subacute torsion. The left testes was seen in the inguinal canal already atrophied by that time. Subsequently, on surgical exploration the right testis was found atrophied in the inguinal canal, and was replaced in the right sub-dartose pouch, but left testis could not be identified. Surprisingly, 4 months later laparoscopic exploration failed to identify either of the testes except for bilateral atrophied gubernaculum, indicating testicular regression. At the age of 7 years, magnetic resonance imaging confirmed the absence of either of the testes, with no remnants. On examination his height was 146.5cm, which was between the 25th and 50th percentile for that age, and below his mid-parental height range. He had no androgenic hair growth, testes were impalpable and had a prepubertal penis accounting to tanner stage of 1. He had hypergonadotrophic hypogonadism. Pubertal induction was done with testosterone injections which resulted in height gain and development of secondary sexual characteristics.Introduction: The entity Vanishing testicle syndrome (VTS) was coined by Abryaratne et al. in 1969, and is also referred to as "Testicular regression syndrome" [1][2]. The two essential diagnostic criteria are; visualizing the blind-ending spermatic vessels within the retro-peritoneum or spermatic vessels and vas deferens exiting a closed internal inguinal ring, and Testis not palpated during examination under anaesthesia[2][3]. A small fibrotic nodule or nubbin with dystrophic calcification and haemosiderin deposition is usually found at the end of the spermatic cord, with or without identifiable testicular or para-testicular structures [2][3]. Cryptorchidism is reported in 1 -4.6% full term and 1.1 -45.3% pre-mature male infants [4]. This prevalence of cryptorchidism decreases to 1 % by the age of 1 year [5]. Testes are non-palpable in 10 -20% cases of cryptorchidism, and of these VTS accounts for 35 - 60% [6] VTS occurs in < 5% cases of cryptorchidism [7]. VTS is estimated to affect 1:1250 males [8]. We present a rare case of bilateral VTS in a 12 year old boy who presented with short stature and absent secondary sexual characteristics with unpalpable testes.
- Open Access
- 8 August 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 14  (2) , 58-60
When growth exceeds boundaries: Tall stature, enlarged hands & feet – Is it what you think?
- 8 August 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 14  (2) , 58-60
Open AccessWhen growth exceeds boundaries: Tall stature, enlarged hands & feet – Is it what you think?